Episode Details

George Hodgin, Founder and CEO of BRC Therapeutics, joins AlphaNooner to discuss the next frontier of cannabinoid medicine. We'll explore how BRC is navigating the FDA drug approval process, why pharmaceutical-grade cannabinoids could reshape pain management and other unmet medical needs, and what investors should know as cannabis evolves from a consumer product into a biotech opportunity. George is a former Navy SEAL and Stanford MBA who founded BRC to develop federally compliant cannabinoid therapeutics.

AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the stories shaping what comes next.

Watch the full video on YouTube: https://www.youtube.com/watch?v=IjWTM2BjG6A

Follow AdvisorShares (@advisorshares) on YouTube, X, LinkedIn, Instagram and Facebook.